Project Overview

Shivom OMX

Shivom is powering the next era of genomics through blockchain technology


Ticker

OMX

Country

United Kingdom

Industries

Website

Contact Email

henryines@yahoo.com


White paper

Platform

Total Supply

3000000000 OMX


Social Media

Google Plus

YouTube Channel

Discord

Github

Steemit

Instagram

Project Description


Description

Shivom is powering the next era of genomics through blockchain technology – by protecting identity, personalizing healthcare, transforming lives. Our blockchain based genomics and healthcare platform will allow the transition to value-based precision healthcare. Our focus is on the transformational convergence of OMICS technologies with blockchain, artificial intelligence and machine learning to enable secure and personalized medicine with global scalability.
We envision a future where genomic data becomes ubiquitous, with its insights for enhancing healthcare securely available and accessible to all. Shivom is pioneering the omics ecosystem to make this vision a reality by offering a first-of-its-kind investment proposition in the rapidly growing market for personalized medicine, powered by state-of-the-art blockchain technology.
We will additionally build a state-of-the art and not-for-profit drug discovery and precision medicine organization. Shivom researchers will use data-driven tools and techniques, particularly machine learning methods that underpin artificial intelligence, which will offer promise in improving healthcare systems and services around the globe.
Blockchain technology is our tech partner of choice because it is able to address trust issues, including patient consent, data ownership, data integrity, and authentication.
Blockchain can also manage complex data rights and allow finegrained access using smart contracts.

ICO Overview

Ticker

OMX

Accepted Payment Methods

MVP?

KYC/Whitelist

KYC & Whitelist

Soft Cap

12960

Hard Cap

64802

Restricted Countries

Bounty Program


Airdrop Overview

Current Status: Unknown

Description

Amount Available

Start Date

End Date


Private-Sale Overview

Current Status: Unknown

Private Sale Price

Private Sale Goal

Private Sale Min Contribution

Private Sale Available for Sale

Private Sale Start Date

Private Sale End Date


Pre-Sale Overview

Current Status: Unknown

Price

Goal

Minimum Contribution

Available for Pre-Sale

Pre-Sale Start Date

Pre-Sale End Date


Public Sale Overview

Current Status: Complete

Public Sale Price

7142

Available For Sale

990000000 OMX

Public Sale Minimum Contrabution

Public Sale Start Date

April 16, 2018

Public Sale End Date

May 16, 2018

group

Team Members

Dr. Axel Schumacher

Co-Founder & CEO

Gourish Singla

Co-Founder & COO

Sally Eaves

Co-Founder & CMO

Per Lind

Co-Founder & CSO

Akash Gaurav

Co-Founder & CTO

Henry Ines

Chief Innovation Officer

Agam Kansal

VP Marketing

school

Project Advisors

Kumar Gaurav

Co-Founder & Chief Technology Advisor

rss_feed

Twitter

announcement

Press Releases

announcement

Featured ICOs